IN THE NEWS

Media Coverage

20/09/2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients’ Immunotherapy Response

Read More>
Precision Oncology news

20/09/2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients’ Immunotherapy Response

Read More>
360

20/09/2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients’ Immunotherapy Response

Read More>
genomeweb

10/09/2021

Oncohost platform predicts response to lung cancer therapy

Read More>
Bioworld

News Releases

13/09/2021

OncoHost Publishes Data Identifying Predictive Signature for Response to Immunotherapy in Lung Cancer Patients

Study Demonstrates Potential Clinical Utility of Analyzing Proteomic Changes in Plasma During ICI Therapy to Predict Individual Patient Response

Read More>
Cision

18/08/2021

OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

Leading Award Recognizes OncoHost's Commitment to Innovation and Significant Accomplishments in Advancing Predictive Analytics to Improve Cancer Care

Read More>
Cision

16/06/2021

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

OncoHost's AI-Based Proteomic Profiling Platform, PROphet®, to Serve Key Role in Host Response Evaluation of Late-Stage Disease Patients

Read More>
Cision

19/01/2021

OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform

On a Mission to Match Individual Cancer Patients with the Most Effective Treatment, Investment will Expand Clinical Trials, Support Opening of a US Office and Preparation for Commercial Launch

Read More>
Cision

Videos

17/02/2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer

Watch the video >
Docwirenews

31/12/2020

OncoHost – Personalized cancer therapy for more effective treatment

Watch the video >
Our Crowd

05/06/2020

PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

Watch the video >
tech-nology

04/06/2020

PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

Watch the video >
tech-nology

Awards

25/08/2021

Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test

Read More>
AACC

01/08/2021

2021 Technology Innovation Leadership

European AI-based
Precision Oncology Industry
Excellence in Best Practices

Read PDF >
2021 Technology Innovation Leadership